SB 401·LA·senate
PHARMACEUTICALS: Provides for a Prescription Drug Affordability Board. (8/1/26)
Signed into LawFiled Feb 27, 2026
Sponsor: Kirk Talbot (R)
Latest Action
Signed by the Governor. Becomes Act No. 915.
Jun 12, 2026
Summary
The bill establishes a Prescription Drug Affordability Board to review drug pricing in Louisiana. It adds a patient‑advocacy representative to the board and imposes strict conflict‑of‑interest rules for members. It also defines key pricing terms such as research and development expenditures and wholesale acquisition cost.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get an email when SB 401 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track SB 401 freeOr ask your AI assistant about SB 401 directly:
Add to Claude, ChatGPT or Cursor